|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 37/02 | |||
| C12N 5/20 |
| (11) | Number of the document | 2177537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10150359.7 |
| Date of filing the European patent application | 2005-01-07 | |
| (97) | Date of publication of the European application | 2010-04-21 |
| (45) | Date of publication and mention of the grant of the patent | 2011-08-31 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 535490 P | 2004-01-09 | US |
| (72) |
Pullen, Nicholas, GB
Molloy, Elizabeth, GB
Kellermann, Sirid-Aimee, US
Green, Larry L., US
Haak-Frendscho, Mary, US
|
| (73) |
Pfizer Limited,
Ramsgate Road, Sandwich, Kent CT13 9NJ,
GB
Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US |
| (54) | Antibodies to MAdCAM |
| Antibodies to MAdCAM |